AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
AFT Pharmaceuticals has struck a deal with Hainan Haiyao Co. Ltd to distribute its innovative skin infection treatment, Crystaderm cream, in China’s vast pharmaceutical market. Crystaderm offers a novel approach to treating skin infections by releasing hydrogen peroxide, providing an alternative to traditional topical antibiotics. Both companies express enthusiasm for the product’s potential in meeting the unmet clinical demand in the Chinese market.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.